These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8200287)

  • 1. [Significance of platelet aggregation in patients with malignant tumor of the head and neck].
    Nong HT
    Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):454-7. PubMed ID: 8200287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Observation on platelet aggregative ability in patients with malignant tumors of head and neck by electron microscope].
    Zheng Y; Liang C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Oct; 33(5):270-2. PubMed ID: 11717864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of folate, homocysteine, and vitamin B12 in head and neck squamous cell carcinoma and in laryngeal leukoplakia.
    Almadori G; Bussu F; Galli J; Cadoni G; Zappacosta B; Persichilli S; Minucci A; Giardina B; Maurizi M
    Cancer; 2005 Jan; 103(2):284-92. PubMed ID: 15593092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Illness stage and IgA-anti-Fab/F(ab')2 autoantibody activity in serum of patients with malignant head-neck tumors].
    Lorenz KJ; Süsal C; Opelz G; Maier H
    Laryngorhinootologie; 1996 Dec; 75(12):764-8. PubMed ID: 9081283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck.
    Hoffmann TK; Sonkoly E; Homey B; Scheckenbach K; Gwosdz C; Bas M; Chaker A; Schirlau K; Whiteside TL
    Head Neck; 2007 May; 29(5):472-8. PubMed ID: 17111427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of 7878 patients with tumors in the head and neck].
    You MG
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):282-7. PubMed ID: 2625111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of serum soluble tumor necrosis factor receptor-I in patients with head and neck neoplasm].
    Dong W; Xu J; Qiao Z; Wang N; Yu R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):468-70. PubMed ID: 12761967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation in head and neck tumors in China.
    Huang GW; Nong HT; Yu QS; Kinjoh K; Nakamura M; Kosugi T
    Laryngoscope; 1997 Aug; 107(8):1142-5. PubMed ID: 9261023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On cervical lymph node metastasizing of malignant tumors with special reference to unknown primary tumors].
    Stricker G
    Monatsschr Ohrenheilkd Laryngorhinol; 1969; 103(4):174-82. PubMed ID: 5783323
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.
    Gross ND; Ellingson TW; Wax MK; Cohen JI; Andersen PE
    Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):169-73. PubMed ID: 14967745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the tumor marker TAG-72 in head and neck neoplasms].
    Altissimi G; von Garrel C
    HNO; 1990 Oct; 38(10):364-6. PubMed ID: 2283330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
    Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
    Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas].
    Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum immune-reactive proteins with clinical tumor stage in patients with squamous carcinoma of the head and neck and nasopharyngeal carcinoma.
    Baskies AM; Chretien PB; Wolf GT; Weiss JF
    Surg Forum; 1979; 30():516-8. PubMed ID: 538683
    [No Abstract]   [Full Text] [Related]  

  • 19. Role for postoperative radiation therapy in adenoid cystic carcinoma of the head and neck.
    Silverman DA; Carlson TP; Khuntia D; Bergstrom RT; Saxton J; Esclamado RM
    Laryngoscope; 2004 Jul; 114(7):1194-9. PubMed ID: 15235347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
    Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.